BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/21/2024 6:35:08 AM | Browse: 119 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 92840
Country United States
Category Oncology
Manuscript Type Retrospective Study
Article Title Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades
Manuscript Source Invited Manuscript
All Author List Ayrton Bangolo, Pierre Fwelo, Shraboni Dey, Tanni Sethi, Sowmya Sagireddy, Jawaria Chatta, Ashish Goel, Sneha Nagpaul, Eric Pin-Shiuan Chen, Chiranjeeve Saravanan, Sheeja Gangan, Joel Thomas, Sarah Potiguara, Vignesh K Nagesh, Daniel Elias, Charlene Mansour, Prajakta H Ratnaparkhi, Priyanshu Jain, Midhun Mathew, Taylor Porter, Shadiya Sultan, Shailaja Abbisetty, Linh Tran, Megha Chawla, Abraham Lo, Simcha Weissman and Christina Cho
Funding Agency and Grant Number
Corresponding Author Ayrton Bangolo, Doctor, MBBS, MD, Doctor, Doctor, Department of Internal Medicine, Palisades Medical center, 7600 River road, North Bergen, NJ 07047, United States. ayrtonbangolo0@gmail.com
Key Words Extra nodal lymphoma; Mortality; Survival; Racial disparity; Age
Core Tip Hepatosplenic T-cell lymphoma (HSTCL) is an uncommon and highly aggressive form of non-Hodgkin lymphoma that carries a very poor prognosis. Very little is known about the survival outcomes of patients with HSTCL given its rarity. This study will be the most updated and largest study on the survival outcomes of patients with HSTCL. We found that older age and Non-Hispanic black ethnicity are the single most important factors for poor prognosis.
Citation <p>Bangolo A, Fwelo P, Dey S, Sethi T, Sagireddy S, Chatta J, Goel A, Nagpaul S, Chen EPS, Saravanan C, Gangan S, Thomas J, Potiguara S, Nagesh VK, Elias D, Mansour C, Ratnaparkhi PH, Jain P, Mathew M, Porter T, Sultan S, Abbisetty S, Tran L, Chawla M, Lo A, Weissman S, Cho C. Characteristics and distinct prognostic determinants of individuals with hepatosplenic T-cell lymphoma over the past two decades. <i>World J Clin Oncol</i> 2024; 15(6): 745-754</p>
Received
2024-02-23 13:19
Peer-Review Started
2024-02-23 13:19
To Make the First Decision
Return for Revision
2024-04-29 20:55
Revised
2024-05-01 02:22
Second Decision
2024-05-21 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-05-21 06:35
Articles in Press
2024-05-21 06:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-05-29 08:34
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com